Day 2 Talks
Message : Don't hesitate to go below upwards on crurals
Talk by THE Peter Schneider. Logic is : Branches come off at caudal angle; distal end of occlusion softer than proximal; pedal and calf / shin punctures are safe.
Mentions importance of dorsi and plantar flexion of the foot to help get the wire up
Usually sheathless and then an 0.018. Need good support catheters : CXI or QuickCross.
CLICK ON THE IMAGE OF FIRST SLIDE ABOVE TO SEE ENTIRE TALK
Content Heavy Talk on BTK Technique!
1. Don't use 0.035 for BTK
2. Put two sharp bends in the wire for CTOs
3. Favoured wires : Regalia XS1, Chevalier floppy, Jupiter FC3, Command.
4. Emphasis on the tip weight depending upon purpose of the wire. Chev tapered 15 / 30; Jupiter 45g; Astato XS 9-12 and 9-40
5. Drilling guidewires : Ruby, Treasure
6. Preference is to go intimal by gentle drilling; when too calcified, go suboptimal.
7. The Microknuckle technique : advancing with just the catheter
CLICK PIC ABOVE TO SEE FULL TALK
TOBA!!!
Tack Optimised Balloon Angioplasty - essentially, short stents.
A set of 4 self expanding NiTinol stents with gold RO markers on a single delivery shaft. Trial is at 6 sites in EU and NZ.
TOBA II for BTK is now recruiting at 60 sites in US EU NZ. Apparently very much AHEAD of targets - (couldn't be more different to BASIL 2!!!)
Thomas Zeller : Lithoplasty!
Lithotripsy incorporated into an angioplasty balloon!
30" at 4 atm, then another 30" at 6 atm; up to 6 such cycles in total; 1 shock per second.
Presently only available in 60 mm balloon length. Safety data acceptably good. Quotes luminal gain in the SFA study DISRUPT 1 to have been 3 mm.
The BullFrog Device! Pumping Steroids in!
DANCE study completed - Above Knee with Dexamethasone
LIMBO and TANGO enrolling
LIMBO ATX (atherectomy and steroid, US only); LIMBO PTA (angioplasty and steroid, EU only
Dexa at dose of 0.8 mg/cm of lesion.
TANGO : Dexa + a Limus drug in BTK!
Two Rx arms, low and high dose of drug. Efficacy check with TVAL : Transverse Vessel Area Loss
Mentions TWIST : first polypharmacy trial